Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05617352

The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study

Conditions: Esophageal Cancer

Sex: All
Ages: 18 Years – 90 Years
Enrollment: 1659
Sponsor: Yongtao Han

Location: China

Summary

To clarify the effect of Two-field or Three-field Lymphadenectomy on the survival of esophageal squamous cell carcinoma.

Eligibility Criteria

Inclusion Criteria:1. Men and women aged 18-85 years2. Histologically confirmed primary thoracic esophageal squamous cell carcinoma,3. Staging PT1b-4A, N0-3, M0 AJCC eighth edition4. Excluding lymph node dissection < 15, (meeting the guideline criteria)5. The tumor located in the lower middle thoracic.Exclusion Criteria:1. Patients with a history of previous thoracic and abdominal surgery that may affect lymphatic reflux2. Patients with distant metastasis confirmed by imaging3. Patients with obvious surgical contraindications.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05617352). StuddyBuddy aggregates publicly available trial information.